It's exciting to hear that the first FDA-approved phase I clinical trial is under way for the pioneering stem cell treatment for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), a condition for which there has not been a cure. Thanks to Nueralstem, Inc which provided the spinal cord stem cells, new hope has been given to ALS sufferers.
ALS is a progressive fatal neurodegenerative disease that affects nerve cells in the brain, leading to the degeneration and death of the motor neurons in the spinal cord that control muscle movement.
No comments:
Post a Comment